106 related articles for article (PubMed ID: 32304153)
21. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
22. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16
Kawashita S; Matsuda K; Kondo H; Kitajima Y; Hasegawa Y; Shimada T; Kitajima M; Miura K; Nakashima M; Masuzaki H
Cancer Control; 2020; 27(1):1073274819901170. PubMed ID: 32077330
[TBL] [Abstract][Full Text] [Related]
23. Application of p16 Immunohistochemistry and RNA In Situ Hybridization in the Classification of Adenoid Basal Tumors of the Cervix.
Goyal A; Wang Z; Przybycin CG; Yang B
Int J Gynecol Pathol; 2016 Jan; 35(1):82-91. PubMed ID: 26352551
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
27. Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: a clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies.
Ruhoy SM; Guinee DG; Nuovo G
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):253-61. PubMed ID: 24717230
[TBL] [Abstract][Full Text] [Related]
28. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
29. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
30. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus infection in oral squamous cell carcinomas from Chilean patients.
Reyes M; Rojas-Alcayaga G; Pennacchiotti G; Carrillo D; Muñoz JP; Peña N; Montes R; Lobos N; Aguayo F
Exp Mol Pathol; 2015 Aug; 99(1):95-9. PubMed ID: 26057833
[TBL] [Abstract][Full Text] [Related]
32. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
33. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
[TBL] [Abstract][Full Text] [Related]
34. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J
Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596
[TBL] [Abstract][Full Text] [Related]
36. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors.
Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z
Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963
[TBL] [Abstract][Full Text] [Related]
37. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
38. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.
Masumoto N; Fujii T; Ishikawa M; Saito M; Iwata T; Fukuchi T; Susumu N; Mukai M; Kubushiro K; Tsukazaki K; Nozawa S
Hum Pathol; 2003 Aug; 34(8):778-83. PubMed ID: 14506638
[TBL] [Abstract][Full Text] [Related]
39. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
[TBL] [Abstract][Full Text] [Related]
40. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]